Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.39
-0.01
(-0.01%)
After-Hours: 20:00
Haemonetics Total Liabilities (Quarterly) : 1.528B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.528B |
| March 31, 2026 | 1.600B |
| December 31, 2025 | 1.579B |
| September 30, 2025 | 1.593B |
| June 30, 2025 | 1.580B |
| March 31, 2025 | 1.630B |
| December 31, 2024 | 1.624B |
| September 30, 2024 | 1.646B |
| June 30, 2024 | 1.636B |
| March 31, 2024 | 1.236B |
| December 31, 2023 | 1.257B |
| September 30, 2023 | 1.118B |
| June 30, 2023 | 1.098B |
| March 31, 2023 | 1.117B |
| December 31, 2022 | 1.102B |
| September 30, 2022 | 1.136B |
| June 30, 2022 | 1.050B |
| March 31, 2022 | 1.110B |
| December 31, 2021 | 1.101B |
| September 30, 2021 | 1.103B |
| June 30, 2021 | 1.117B |
| March 31, 2021 | 1.088B |
| December 31, 2020 | 598.92M |
| September 30, 2020 | 750.25M |
| June 30, 2020 | 824.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 680.00M |
| December 31, 2019 | 663.17M |
| September 30, 2019 | 606.79M |
| June 30, 2019 | 668.64M |
| March 31, 2019 | 606.90M |
| December 31, 2018 | 584.51M |
| September 30, 2018 | 564.37M |
| June 30, 2018 | 567.11M |
| March 31, 2018 | 484.91M |
| December 31, 2017 | 488.91M |
| September 30, 2017 | 469.91M |
| June 30, 2017 | 478.61M |
| March 31, 2017 | 499.10M |
| December 31, 2016 | 535.52M |
| September 30, 2016 | 585.71M |
| June 30, 2016 | 601.83M |
| March 31, 2016 | 597.56M |
| December 31, 2015 | 616.87M |
| September 30, 2015 | 642.06M |
| June 30, 2015 | 635.76M |
| March 31, 2015 | 659.30M |
| December 31, 2014 | 640.24M |
| September 30, 2014 | 653.83M |
| June 30, 2014 | 661.66M |
| March 31, 2014 | 676.29M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | 20.04B |
| Integra LifeSciences Holdings Corp. | 2.520B |
| Globus Medical, Inc. | 719.66M |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.365B |
| Shareholders Equity (Quarterly) | 837.10M |
| Debt to Equity Ratio | 1.403 |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | 0.64% |